Skip to main content
. 2020 Sep 20;22(11):2077–2083. doi: 10.1111/jch.14040

Table 1.

Baseline characteristics of hypertensive patients, stratified by number of laboratory tests received within first year of diagnosis

Variables a No testing Testing (1 panel) Testing (2 panels) Testing (3 or 4 panels) Any testing (≥1 panel)
Total 57 974 8240 36 100 122 982 167 322
Male — no. (%) 34 430 (59.4) 4536 (55.0) 18 634 (51.6) 68 804 (55.9) 91 974 (55.0)
Age ≥ 65 — no. (%) 8711 (15.0) 1611 (19.6) 10 005 (27.7) 31 140 (25.3) 42 756 (25.6)
Age — median (25‐75th percentiles) 51.2 (42.5‐60.0) 53.8 (45.4‐62.5) 55.4 (45.6‐66.6) 56.1 (47.5‐65.1) 55.9 (47.0‐65.2)
Comorbidities—no. (%)
Diabetes mellitus 2076 (3.6) 693 (8.4) 3119 (8.6) 18 041 (14.7) 21 853 (13.1)
Chronic kidney disease 385 (0.7) 86 (1.0) 1783 (4.9) 4981 (4.1) 6850 (4.1)
Congestive heart failure 929 (1.6) 177 (2.1) 2854 (7.9) 7166 (5.8) 10 197 (6.1)
Coronary artery disease 934 (1.6) 219 (2.7) 2112 (5.9) 9155 (7.4) 11 486 (6.9)
Stroke 1295 (2.2) 331 (4.0) 2750 (7.6) 7837 (6.4) 10 918 (6.5)
Charlson index of 1 or 2 13 288 (22.9) 2668 (32.4) 12 421 (34.4) 42 400 (34.5) 57 489 (34.4)
Charlson index ≥ 3 1652 (2.8) 535 (6.5) 6550 (18.1) 17 199 (14.0) 24 284 (14.5)
Hospitalized for any reason within 1st year of diagnosis 2904 (5.0) 888 (10.8) 13 086 (36.2) 27 224 (22.1) 41 198 (24.6)
a

Comorbidities are based on physician and hospital billing codes.